INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Open-market purchaseVerified data

Dalton Travis bought CTEV

Director, Pres., CEO & Executive Chair · Claritev Corp · Class A common stock

Side
BUY
Value
$250K
Shares
5,290
Price
$47.23
Executed
Nov 20, 2025
Disclosed
Nov 20, 2025
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Nov 20 executedNov 20, 2025 disclosed

CTEV · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
54/ 100 · NOTABLE
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+16 / 25

    $250K reported value · 123.5% of prior position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+10 / 15

    2 other actors traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CTEV

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    ME
    Main Jennifer ElizabethDirector
    CTEVClaritev Corp
    Grant or award
    		A—
    3,113 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    8
    MT
    Misencik TiffaniSVP, Chief Growth Officer
    CTEVClaritev Corp
    Open-market sale · 10b5-1 plan
    		SELL$138K
    5,812 sh
    		Oct 15, 2026Oct 16, 2026
    traded Oct 15, 2026
    		+1dSEC FORM 4

    Evidence

    2
    MT
    Misencik TiffaniSVP, Chief Growth Officer
    CTEVClaritev Corp
    Tax withholding · 10b5-1 plan
    		F$239K
    9,994 sh
    		Oct 14, 2026Oct 16, 2026
    traded Oct 14, 2026
    		+2dSEC FORM 4

    Evidence

    15
    GM
    Garis Douglas MichaelEVP&CFO
    CTEVClaritev Corp
    Open-market sale · 10b5-1 plan
    		SELL$240K
    7,877 sh
    		Sep 21, 2026Sep 22, 2026
    traded Sep 21, 2026
    		+1dSEC FORM 4

    Evidence

    12
    GM
    Garis Douglas MichaelEVP&CFO
    CTEVClaritev Corp
    Open-market sale · 10b5-1 plan
    		SELL$36K
    1,148 sh
    		Sep 21, 2026Sep 22, 2026
    traded Sep 21, 2026
    		+1dSEC FORM 4

    Evidence

    9
    LB
    Letham Thomas BenjaminDirector
    CTEVClaritev Corp
    Grant or award
    		A—
    2,880 sh
    		Sep 14, 2026Sep 16, 2026
    traded Sep 14, 2026
    		+2dSEC FORM 4

    Evidence

    36
    MT
    Misencik TiffaniSVP, Chief Growth Officer
    CTEVClaritev Corp
    Open-market sale
    		SELL$355K
    8,850 sh
    		Aug 14, 2026Aug 18, 2026
    traded Aug 14, 2026
    		+4dSEC FORM 4

    Evidence

    43
    MB
    Mintz William B.SVP, Chief Strategy Officer
    CTEVClaritev Corp
    Open-market sale
    		SELL$289K
    8,431 sh
    		Aug 10, 2026Aug 12, 2026
    traded Aug 10, 2026
    		+2dSEC FORM 4

    Evidence

    15
    GM
    Garis Douglas MichaelEVP&CFO
    CTEVClaritev Corp
    Tax withholding
    		F$306K
    11.7K sh
    		Aug 5, 2026Aug 7, 2026
    traded Aug 5, 2026
    		+2dSEC FORM 4

    Evidence

    8
    MB
    Mintz William B.SVP, Chief Strategy Officer
    CTEVClaritev Corp
    Tax withholding
    		F$95K
    3,622 sh
    		Aug 5, 2026Aug 7, 2026
    traded Aug 5, 2026
    		+2dSEC FORM 4

    Evidence

    29
    CN
    Carol NutterSVP, Chief People Officer
    CTEVClaritev Corp
    Open-market purchase
    		BUY$25K
    875 sh
    		Jun 9, 2026Jun 10, 2026
    traded Jun 9, 2026
    		+1dSEC FORM 4

    Evidence

    21
    PM
    Prince John MichaelDirector
    CTEVClaritev Corp
    Grant or award
    		A—
    8,977 sh
    		Apr 29, 2026May 1, 2026
    traded Apr 29, 2026
    		+2dSEC FORM 4

    Evidence

    21
    KL
    Kap Jason LamarDirector
    CTEVClaritev Corp
    Grant or award
    		A—
    8,977 sh
    		Apr 29, 2026May 1, 2026
    traded Apr 29, 2026
    		+2dSEC FORM 4

    Evidence

    34
    GM
    Garis Douglas MichaelEVP&CFO
    CTEVClaritev Corp
    Open-market purchase
    		BUY$23K
    1,300 sh
    		Mar 16, 2026Mar 16, 2026
    traded Mar 16, 2026
    		+0dSEC FORM 4

    Evidence

    30
    OT
    O'Neil TaraSVP, General Counsel
    CTEVClaritev Corp
    Open-market purchase
    		BUY$9,743
    750 sh
    		Mar 2, 2026Mar 2, 2026
    traded Mar 2, 2026
    		+0dSEC FORM 4

    Evidence

    9
    OT
    O'Neil TaraSVP, General Counsel
    CTEVClaritev Corp
    Grant or award
    		A—
    1,421 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    13
    HJ
    Hogge JeromeEVP, Chief Operating Officer
    CTEVClaritev Corp
    Grant or award
    		A—
    8,723 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    13
    CN
    Carol NutterSVP, Chief People Officer
    CTEVClaritev Corp
    Grant or award
    		A—
    1,884 sh
    		Feb 18, 2026Feb 20, 2026
    traded Feb 18, 2026
    		+2dSEC FORM 4

    Evidence

    39
    MB
    Mintz William B.SVP, Chief Strategy Officer
    CTEVClaritev Corp
    Open-market purchase
    		BUY$35K
    916 sh
    		Nov 17, 2025Nov 19, 2025
    traded Nov 17, 2025
    		+2dSEC FORM 4

    Evidence

    39
    OT
    O'Neil TaraSVP, General Counsel
    CTEVClaritev Corp
    Open-market purchase
    		BUY$24K
    625 sh
    		Nov 17, 2025Nov 18, 2025
    traded Nov 17, 2025
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001841409-25-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 20, 2025
    Published
    Nov 20, 2025
    Ingested by INSIDER
    Nov 5, 04:32 UTC
    Last re-read
    Nov 5, 04:32 UTC

    Extracted facts

    Filer
    Dalton Travis
    Role
    Director, Pres., CEO & Executive Chair
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    Claritev Corp
    Ticker
    CTEV
    Shares
    5,290
    Price per share
    $47.23
    Value
    $249,842
    Execution date (reported)
    Nov 20, 2025
    Owned after transaction
    9,572 shares
    Days from execution to publication
    0

    Calculation

    Value = shares × reported price per share

    • Shares: 5,290
    • Price: $47.2291

    = $249,842

    What this establishes

    Dalton Travis filed this Form 4 reporting a open-market purchase of CTEV on Nov 20, 2025. It became public on Nov 20, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, Pres., CEO & Executive Chair
    Dalton Traviscik:0001841409
    Issuer
    Claritev Corpcik:0001793229

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.